Caged-hypocrellin-mediated antimicrobial photodynamic therapy as a dual-action strategy for fungal clearance and immune response regulation in drug-resistant Candida auris wound infections
Journal of the American Academy of Dermatology · 2026
DOI: 10.1016/j.jaad.2025.08.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Xinyao Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pathogen Research, West China Hospital, Sichuan University, Chengdu, China; Department of Dermatovenereology, West China Hospital, Sich…. Hauptthemen laut MEDLINE: Photochemotherapy, Wound Infection, Candida auris, Photosensitizing Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Ministry of Science and Technology of the People's Republic of China, Sichuan University.
Abstract (Originalsprache)
BACKGROUND: Multidrug-resistant Candida auris is designated by the World Health Organization as a critical priority pathogen. Its bloodstream infections have ∼40% mortality and predominant cutaneous origin, necessitating early local control. With limited treatment options, new antifungal strategies are urgently needed. Antimicrobial photodynamic therapy (aPDT) has shown promise for superficial infections, although its immune-modulating mechanisms remain unclear. OBJECTIVE: To assess antifungal and immunomodulatory effects of aPDT on multidrug-resistant C. auris skin wound infection. METHODS: A murine wound model using C. auris CBS14918 was treated with COP1T-HA-based aPDT. Fungal burden, wound healing, immune profiles, and transcriptomic responses were evaluated. COP1T-only and dark groups were excluded from immunological analyses because prior validation revealed a lack of efficacy. RESULTS: aPDT significantly reduced fungal burden and accelerated wound healing. It enhanced local infiltration of myeloid cells, B cells, γδ T cells, and type 2 innate lymphoid cells, while controlling systemic inflammation. Transcriptomic data confirmed a balanced cytokine profile supporting fungal clearance and tissue repair. LIMITATIONS: The study used only animal models, as proof-of-concept therapies cannot be ethically tested in humans. CONCLUSIONS: aPDT eradicates drug-resistant C. auris and enhances wound healing via immune modulation. These effects support its potential as a preclinical strategy when human studies are ethically prohibited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pathogen Research, West China Hospital, Sichuan University, Chengdu, China; Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China.
- Laboratory of Infectious Diseases and Vaccine, West China Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Bioresources and Ecoenvironment (Ministry of Education), College of Life Sciences, Sichuan University, Chengdu, China.
- Laboratory of Pathogen Research, West China Hospital, Sichuan University, Chengdu, China; Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, China.
- Department of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology; The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE) Shanghai Changzheng Hospital, Naval Medical University, Shang…
- ShenYunZhiHe Company, Qidian BLDG, Beijing, China.
Förderung
- National Key Research and Development Program of China
- Ministry of Science and Technology of the People's Republic of China
- Sichuan University
- Scientific Research and Technology Development Program of Guangxi Zhuang Autonomous Region
- West China Hospital, Sichuan University
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Guo, S., Wang, J., Zhang, L., Lin, Y., Liu, Y., Ouyang, J., Shi, D., Xu, B., Fang, W., & Ran, Y. (2026). Caged-hypocrellin-mediated antimicrobial photodynamic therapy as a dual-action strategy for fungal clearance and immune response regulation in drug-resistant Candida auris wound infections. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2025.08.040
Vancouver
Liu X, Guo S, Wang J, Zhang L, Lin Y, Liu Y, et al. Caged-hypocrellin-mediated antimicrobial photodynamic therapy as a dual-action strategy for fungal clearance and immune response regulation in drug-resistant Candida auris wound infections. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2025.08.040
BibTeX
@article{Liu2026,
author = {Liu, Xinyao and Guo, Shaohua and Wang, Jiao and Zhang, Linwan and Lin, Yusong and Liu, Yuzhou and Ouyang, Jiangshan and Shi, Dongmei and Xu, Bin and Fang, Wenjie and Ran, Yuping},
title = {Caged-hypocrellin-mediated antimicrobial photodynamic therapy as a dual-action strategy for fungal clearance and immune response regulation in drug-resistant Candida auris wound infections},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2025.08.040}
}
EUVIMED